On March 22, 2010, the Federal Circuit issued an important en banc decision upholding a separate written description requirement under 35 U.S.C. § 112. In Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co., the Court rejected the patent owner’s contention
You Can’t Patent Basic Research, En Banc Federal Circuit Rules; Harvard Loses 9-2
You know something odd has happened in the law when a court takes 38 pages to say a basic thing — like that a patent must describe the invention it aims to cover.
The 11-judge Federal Circuit did just that today,…